Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
However, these should be introduced gradually to assess individual tolerance
Discussing these with your healthcare provider can help find the best fit
Immunogenicity: No participants in clinical trials developed anti-AOD-9604 antibodies, indicating the peptide does not trigger immune responses even with repeated dosing
Your provider may recommend imaging studies, gastric-emptying tests, or referral to a gastroenterologist if gastroparesis is suspected
Nov 8: Wednesday turned out to be a big day at the FDA
US$ 21.72
US$ 21.19
US$ 20.15
